The mushroom compound psilocybin has shown promise in rodents as a potential preventative for Chemotherapy‑Induced Peripheral ...
The COVID-19 pandemic left most of the world's population with an immune memory for COVID. Celloram wants to use that memory ...
A new investigational cancer vaccine developed by Merck & Co. and Moderna is customized based on the genome of each patient's ...
AbbVie's MAVYRET became the first of those antivirals cleared for acute infection in June 2025, with a 96% cure rate in trial ...
Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug ...
A WuXi AppTec director examines strategies for improving oral PROTAC exposure, from food-effect studies and linker design to ...
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
The modern GLP-1 era effectively began with semaglutide’s 2017 approval as Ozempic. While the field had evolved considerably since the FDA approval of the first GLP-1 receptor agonist, exenatide ...
Press release: Southampton, PA – NewAge Industries, Inc., parent company of AdvantaPure™ and NewAge Performance Products, a global leader in fluid transfer systems solutions for the biopharma and ...
A new international collaboration backed by a pan-European EUREKA grant aims to develop targeted small-molecule therapies for hyper-inflammatory diseases driven by dysregulated neutrophil activity, ...